Oligodendroglioma Clinical Trials in San Francisco

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Giant Cell Glioblastoma
  • +5 more
  • Bevacizumab
  • +4 more
  • Anchorage, Alaska
  • +243 more
2021-12-21
Dec 21, 2021
U
Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
2021-11-15
Nov 15, 2021
N
Active, not recruiting
  • Glioma
  • +5 more
  • IMA950
  • +2 more
  • San Francisco, California
    University of California
2021-07-08
Jul 8, 2021
E
Active, not recruiting
  • Glioblastoma
  • +2 more
  • RRx-001 dose escalation with TMZ + RT
  • +3 more
  • San Francisco, California
  • +2 more
2020-07-21
Jul 21, 2020